EP-1694: DW-MRI as a predictor of tumor response to hypofractionated stereotactic boost for prostate cancer - Archive ouverte HAL
Conference Papers Year : 2017

Dates and versions

hal-01683897 , version 1 (14-01-2018)

Identifiers

Cite

David Pasquier, A. Hadj Henni, E. Tresch, N. Reynaert, E. Lartigau, et al.. EP-1694: DW-MRI as a predictor of tumor response to hypofractionated stereotactic boost for prostate cancer. ESTRO 36 2017 : European Society for Radiotherapy and Oncology, May 2017, Vienna, France. pp.S926 - S927, ⟨10.1016/S0167-8140(17)32226-0⟩. ⟨hal-01683897⟩
281 View
0 Download

Altmetric

Share

More